Literature DB >> 7565695

Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription.

P K Datta1, P Raychaudhuri, S Bagchi.   

Abstract

The retinoblastoma-related protein p107 has been shown to be a regulator of the transcription factor E2F. p107 associates with E2F via its pocket region and represses E2F-dependent transcription. In this study, we provide evidence for a novel interaction between p107 and the transcription factor Sp1. We show that p107 can be found endogenously associated with Sp1 in the extracts of several different cell lines. Moreover, in transient transfection assays, expression of p107 represses Sp1-dependent transcription. This repression of Sp1-dependent transcription does not require the DNA-binding domain of Sp1. Transcription driven by a chimeric protein containing the Ga14 DNA-binding domain and the Sp1 activation domains is inhibited by p107. Interestingly, unlike the repression of E2F-dependent transcription, the repression of Sp1-dependent transcription does not depend on an intact pocket region. We show that distinct regions of p107 are involved in the control of Sp1 and E2F.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565695      PMCID: PMC230794          DOI: 10.1128/MCB.15.10.5444

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

Review 1.  Adenovirus E1A targets key regulators of cell proliferation.

Authors:  N Dyson; E Harlow
Journal:  Cancer Surv       Date:  1992

2.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F.

Authors:  M Ivey-Hoyle; R Conroy; H E Huber; P J Goodhart; A Oliff; D C Heimbrook
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

4.  Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins.

Authors:  G J Hannon; D Demetrick; D Beach
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

5.  The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E.

Authors:  Y Li; C Graham; S Lacy; A M Duncan; P Whyte
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Cell cycle-specific association of E2F with the p130 E1A-binding protein.

Authors:  D Cobrinik; P Whyte; D S Peeper; T Jacks; R A Weinberg
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

7.  The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.

Authors:  S Sif; A J Capobianco; T D Gilmore
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

8.  Interaction between transcription factors Sp1 and YY1.

Authors:  E Seto; B Lewis; T Shenk
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

9.  Interaction between human cyclin A and adenovirus E1A-associated p107 protein.

Authors:  B Faha; M E Ewen; L H Tsai; D M Livingston; E Harlow
Journal:  Science       Date:  1992-01-03       Impact factor: 47.728

10.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

View more
  26 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors.

Authors:  S Philipsen; G Suske
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

3.  Target gene specificity of E2F and pocket protein family members in living cells.

Authors:  J Wells; K E Boyd; C J Fry; S M Bartley; P J Farnham
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Authors:  M Gunther; M Laithier; O Brison
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

6.  Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression.

Authors:  G Guarguaglini; A Battistoni; C Pittoggi; G Di Matteo; B Di Fiore; P Lavia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

7.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

8.  Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites.

Authors:  Bo Yu; Pran K Datta; Srilata Bagchi
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  Next-generation sequencing reveals regional differences of the α-synuclein methylation state independent of Lewy body disease.

Authors:  L de Boni; S Tierling; S Roeber; J Walter; A Giese; Hans A Kretzschmar
Journal:  Neuromolecular Med       Date:  2011-11-01       Impact factor: 3.843

10.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.